Study Details
Single-dose study to assess pharmacokinetics of solifenacin succinate suspension in children and adolescents
Clinicaltrials.gov ID
Astellas Study ID
905-CL-075
EudraCT ID
2009-017197-21
Condition
Overactive Bladder Disease
Phase
Phase 1
Age
5 years - 17 years
Sex
Female & Male
Product
N/A
Type
Interventional
Trial Dates
Oct 2010 - Aug 2011
Masking
None (Open Label)
Enrollment number
42
A multicenter, open-label, single ascending dose study to evaluate pharmacokinetics, safety and tolerability of solifenacin succinate suspension in pediatric patients aged 5 to 17 years (inclusive) with Overactive Bladder (OAB)
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for Single-dose study to assess pharmacokinetics of solifenacin succinate suspension in children and adolescents? Contact us by filling our your information to the right and we’ll respond to you.